Savara (SVRA) Total Current Liabilities (2010 - 2026)

Savara's (SVRA) quarterly Total Current Liabilities came in at $15.5 million in Q1 2026, up 30.6% year-on-year from $11.9 million in Q1 2025, and down 23.81% on a QoQ basis from $20.4 million in Q4 2025.

Savara (SVRA) Total Current Liabilities (2010 - 2026) Analysis & Trends

Savara (SVRA) has 17 years of Total Current Liabilities data on file, last reported at $15.5 million in Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 30.6% year-over-year to $15.5 million in Q1 2026; TTM through Mar 2026 was $15.5 million, a 30.6% increase from a year earlier, with the FY2025 full-year figure at $20.4 million, up 38.52% from the prior year.
  • Total Current Liabilities for Q1 2026 stood at $15.5 million, down from $20.4 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for SVRA reached as high as $20.4 million in Q4 2025 and fell as low as $3.7 million in Q2 2022.
  • Historically, Total Current Liabilities has averaged $11.1 million across 5 years, with a median of $11.3 million in 2024.
  • Across the five-year window, Total Current Liabilities surged 126.49% in 2022 and tumbled 69.85% in 2023, its largest moves.
  • Year by year, Total Current Liabilities stood at $5.9 million in 2022, then jumped by 80.62% to $10.6 million in 2023, then jumped by 38.94% to $14.7 million in 2024, then soared by 38.52% to $20.4 million in 2025, then slipped by 23.81% to $15.5 million in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $15.5 million in Q1 2026, $20.4 million in Q4 2025, and $16.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Savara 1.24 Bn 1.24 Bn - 15.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.54 Mn
Dec 31, 2025 20.40 Mn
Sep 30, 2025 16.76 Mn
Jun 30, 2025 13.63 Mn
Mar 31, 2025 11.90 Mn
Dec 31, 2024 14.72 Mn
Sep 30, 2024 12.79 Mn
Jun 30, 2024 11.29 Mn
Mar 31, 2024 9.81 Mn
Dec 31, 2023 10.60 Mn
Sep 30, 2023 8.96 Mn
Jun 30, 2023 5.89 Mn
Mar 31, 2023 4.92 Mn
Dec 31, 2022 5.87 Mn
Sep 30, 2022 5.16 Mn
Jun 30, 2022 3.71 Mn
Mar 31, 2022 16.32 Mn
Dec 31, 2021 14.66 Mn
Sep 30, 2021 10.66 Mn
Jun 30, 2021 5.64 Mn